Related posts
TSX and tech up in choppy tradingThis summary was created by AI, based on 2 opinions in the last 12 months.
Based on expert reviews, it can be concluded that iShares China Index ETF (XCH-T) holds a diverse portfolio of large and mid-cap Chinese companies, offering broad exposure to the Chinese market. While there have been challenges in the Chinese stock market in recent years due to political interference, XCH has shown signs of bottoming out and rebounding. Experts recommend starting with a small position and considering adding to the holding if the stock continues to rise, citing a good risk-reward ratio.
Chinese stocks have sucked for 3-4 years due to political interference from Beijing. But XCH bottomed a month ago and is rebounding. If this breaks below $13.74, then that means there are more problems in China. Start with a small position. If this continues to rise, he will add to his holding, currently 3% of his portfolio. Risk-reward is really good.
Doesn’t think 2014 is going to be China’s year. Maybe 2015 will be the year. There’s certainly some recovery in emerging markets banks.
iShares China Index ETF is a Canadian stock, trading under the symbol XCH-T on the Toronto Stock Exchange (XCH-CT). It is usually referred to as TSX:XCH or XCH-T
In the last year, 1 stock analyst published opinions about XCH-T. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for iShares China Index ETF.
iShares China Index ETF was recommended as a Top Pick by on . Read the latest stock experts ratings for iShares China Index ETF.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
1 stock analyst on Stockchase covered iShares China Index ETF In the last year. It is a trending stock that is worth watching.
On 2024-12-12, iShares China Index ETF (XCH-T) stock closed at a price of $21.19.
Holds large and mid-cap Chinese companies with broad exposure.